• Topics

  • Formats

Fierce Life Sciences offers a full suite of news, analysis, and event education, all in one place.

From preclinical research to market and beyond, our team of editors and handpicked experts delivers insights you can source with confidence and events, both virtual and live, that support professional and business growth.

Come experience biopharma with us. #BeFierce

Our Events

The Fierce Life Sciences team develops engaging, content- driven conferences which attract decision makers across the pharmaceutical, biotechnology, and healthcare community. Our conference producers work in collaboration with the award-winning Fierce editorial teams and industry advisory boards to put together compelling event programs.

Fierce Pharma

Our Editors cover the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals, and beyond.

Fierce Biotech

Our Editors provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs, and M&A that happen along the way.

Listen to Fierce Life Science's podcast channel, The Top Line.

Commercial considerations often enter the conversation too late, after critical decisions around trial...

12:00, Thursday, 15 Oct 2026

Managing incentive compensation across a large and diverse portfolio requires more than administering...

11:00, Tuesday, 20 Oct 2026

Where drug delivery leaders come together Pharma, biotech and drug delivery industries will...

07:00, Thursday, 29 Oct 2026 + 1 more

08:10, Friday, 30 Oct 2026

Author(s): Cvent Inc. Life sciences teams invest heavily in congresses and field events....

Monday, 28 Sep 2026

Speakers: Carrie Brubaker, Ph.D., Dr. Mike Taylor, & Dr. Carlos Areia (Digital Science)...

Tuesday, 22 Sep 2026

Published 17 August 2026 Author(s): Digital Science More isn’t necessarily better for R&D...

Wednesday, 9 Sep 2026

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?